Position in PFE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,813,031
+$1,687,347 QoQ
Shares Held
420,692
+3.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MAI Capital Management holds $463,973,037 across 18 Drug Manufacturers - General names. PFE ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
548,990 | $134,195,115 | |
| 2 | ABBV |
AbbVie Inc.
|
577,833 | $125,672,899 | |
| 3 | LLY |
ELI LILLY & Co
|
96,089 | $88,379,779 | |
| 4 | MRK |
Merck & Co., Inc.
|
335,023 | $40,299,916 | |
| 5 | AMGN |
Amgen Inc
|
87,280 | $30,709,468 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
223,761 | $13,571,104 | |
| 7 | PFE |
Pfizer Inc
This page
|
420,692 | $11,813,031 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
44,349 | $6,180,920 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,813,031 | 420,692 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,125,684 | 406,654 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,014,888 | 393,049 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,844,836 | 364,886 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $34,828,791 | 1,374,459 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $36,601,000 | 1,379,608 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,190,222 | 697,658 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $19,202,030 | 686,277 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $19,754,947 | 711,890 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $18,336,552 | 636,907 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,930,069 | 299,369 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,392,551 | 310,593 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $13,204,797 | 323,647 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $17,224,018 | 336,144 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $14,026,130 | 320,524 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $14,008,561 | 267,186 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $12,835,905 | 247,941 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $14,611,568 | 247,444 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,832,705 | 205,364 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,049,729 | 205,560 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $7,325,778 | 202,202 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $6,801,089 | 184,762 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,878,123 | 160,167 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $5,290,963 | 161,803 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $5,106,194 | 156,440 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||